#denmark visit germany 2024

[theroyalsandi]

Danish Royal Family - Queen Mary attending the 25th anniversary celebration of the Nordic embassy complex at Schloss Bellevue in Berlin, Germany. (Photos courtesy of Shutterstock) | October 21, 2024

[covid-safer-hotties]

Also preserved on our archive

By Anthony Robledo

The side effects of newly discovered COVID-19 strain XEC might not be as severe, but is part of the more contagious variant class, experts say.

The Centers for Disease Control and Prevention (CDC) defines XEC as recombinant or hybrid of the strains KS.1.1 and KP.3.3., both from the Omicron family that became the predominant strain in the U.S. late December 2022.

The variant, which first appeared in Berlin in late June, has increasingly seen hundreds of cases in Germany, France, Denmark and Netherlands, according to a report by Australia-based data integration specialist Mike Honey.

XEC has also been reported in at least 25 U.S. states though there could be more as genetic testing is not done on every positive test, RTI International epidemiologist Joëlla W. Adams said.

"We often use what happens in Europe as a good indication of what might happen here," Adams told USA TODAY Friday. "Whenever we're entering into a season where we have multiple viruses occurring at the same time, like we're entering into flu season, that obviously complicates things."

What is the XEC variant? New COVID strain XEC is a recombinant strain of two variants in the Omicron family: KS.1.1 and KP.3.3.

The hybrid strain was first reported in Berlin late June but has spread across Europe, North America and Asia with the countries Germany, France, the Netherlands and Denmark leading cases.

Is the XEC variant more contagious? While there's no indication the XEC strain will increase the severity of virus, it could potentially become a dominant strain as Omicron variants are more contagious. However, current available COVID-19 vaccines and booster shots are particularly protective against XEC as it is a hybrid of two Omicron strains.

"These strains do have the advantage in the fact that they are more transmissible compared to other families, and so the vaccines that are currently being offered were not based off of the XEC variant, but they are related," Adams said.

Like other respiratory infections, COVID-19 and its recent Omicron variants will increasingly spread during the fall and winter seasons as students return to classes, kids spend more time inside and people visit family for the holidays, according to Adams.

How can we protect ourselves from XEC and other variants? The CDC continues to monitor the emergence of variants in the population, according to spokesperson Rosa Norman.

"At this time, we anticipate that COVID-19 treatments and vaccines will continue to work against all circulating variants," Norman said in a statement to USA TODAY. "CDC will continue to monitor the effectiveness of treatment and vaccines against circulating variants."

The CDC recommends that everyone ages 6 months and older, with some exceptions, receive an updated 2024-2025 COVID-19 vaccine to protect against the virus, regardless whether or not you have previously been vaccinated or infected.

Norman urged Americans to monitor the agency's COVID Data Tracker for updates to new variants.

KP.3.1.1:This dominant COVID-19 variant accounts for over 50% of cases, new CDC data shows

What is the dominant strain of COVID in the US? COVID-19 variant KP.3.1.1 is currently the dominant strain accounting for more than half of positive infections in the U.S. according to recent CDC projections.

Between Sept. 1 and Sept. 14, 52.7% of positive infections were of the KP.3.1.1 strain, followed by KP.2.3 at 12.2%, according to the agency's Nowcast data tracker, which displays COVID-19 estimates and projections for two-week periods.

KP.3.1.1 first became the dominant strain in the two-week period, starting on July 21st and ending on August 3rd.

"The KP.3.1.1 variant is very similar to other circulating variants in the United States. All current lineages are descendants of JN.1, which emerged in late 2023," Norman previously told USA TODAY.

COVID XEC symptoms There is no indication that the XEC variant comes with its own unique symptoms.

The CDC continues to outline the basic COVID-19 symptoms, which can appear between two to 14 days after exposure to the virus and can range from mild to severe.

These are some of the symptoms of COVID-19:

Fever or chills Cough Shortness of breath or difficulty breathing Fatigue Muscle or body aches Headache Loss of taste or smell Sore throat Congestion or runny nose Nausea or vomiting Diarrhea

The CDC said you should seek medical attention if you have the following symptoms:

Trouble breathing Persistent pain or pressure in the chest New confusion Inability to wake or stay awake Pale, gray or blue-colored skin, lips, or nail beds

[louisupdates]

Prince William's Royal Night Out

Published Jun 21, 2024 at 4:49 AM EDT | Updated Jun 21, 2024 at 9:44 AM EDT

Prince William visited Germany on Thursday to attend a high-profile soccer match on the evening before his 42nd birthday.

The prince was photographed alongside European royalty at the UEFA Euro 2024 tournament group stage match between England and Denmark. He attended in his capacity as president of the Football Association in Britain, a role he was given by Queen Elizabeth II in 2006.

[…]

William not only met European royalty at the game but also pop royalty, in the form of former One Direction band member Louis Tomlinson.

Footage of the prince and the singer chatting behind the scenes at the stadium has gone viral online. It is not the first time the two have met. The pair were photographed together at the Royal Variety charity performance in 2014 and 2017.

In 2018 when William and Kate named their youngest son Louis, Tomlinson posted a lighthearted social media message dedicated to the prince, including the line: "Young Louis welcome to the world. I'll take you under my wing lad."

[gabriellademonaco]

Queen Mary’s Engagements in Oct 2024:

01/10: Opening of Parliament

02/10: Official Visit to Brazil - Boat Trip on the Amazon, Adolpho Ducke Forest Reserve and the Amazonian Museum MUSA

02/10: Official Visit to Brazil - Official Reception by the Governor of Amazonas

03/10: Official Visit to Brazil - National Research Institute for the Amazon Forest, Center for Bioeconomy, Lunch

04/10: Official Visit to Brazil - Official Meeting with President of Brazil

04/10: Official Visit to Brazil - Public School, Agricultural Research Institute

04/10: Official Visit to Brazil - Working Dinner with UNFPA at Danish Embassy

05/10: Official Visit to Brazil - Botanical Garden with UNEP

08/10: State Visit from Iceland - Day 1

08/10: State Visit from Iceland - Banquet

09/10: State Visit from Iceland - Day 2

09/10: State Visit from Iceland - Return Event

10/10: State Visit from Iceland - Official Farewell

10/10: Christmas Seal

10/10: 25th Anniversary of the American Chamber of Commerce in Denmark

11/10: 750th Anniversary of Holstebro City

21/10: Official Visit to Germany - Official Welcome at Schloss Bellevue, Reception at the Bundestag

21/10: Official Visit to Germany - Nordic Embassy Complex 25th Anniversary

21/10: Official Visit to Germany - Official Dinner

22/10: Official Visit to Germany - Official Welcome in Schleswig-Holstein, Sailing Tour, Energy Conference at GEOMAR, Danevirke, Flensborghus

[ifreakingloveroyals]

Through the Years → Queen Mary of Denmark (938/∞) 21 October 2024 | Queen Mary of Denmark arrives with King Frederik at Schloss Bellevue palace in Berlin, Germany. The Danish Royal Couple are in Berlin to celebrate the 25th anniversary of the Nordic Embassies later today. Tomorrow they will visit the Danish minority in Schleswig-Holstein. (Photo by Sean Gallup/Getty Images)

[usafphantom2]

The Netherlands allocates 350 million euros to Ukraine to acquire air-to-ground weapons for the F-16 and drones

The Pentagon would have insisted that the Ukrainian F-16s should only be used within the borders of Ukraine.

Fernando Valduga By Fernando Valduga 03/21/2024 - 09:00 in Military, War Zones

The Dutch government announced new aid for Ukraine, with the allocation of more than 150 million euros for the purchase of F-16 ammunition and another 200 million euros for the acquisition of ISR drones.

The announcement came from the Minister of Defense of the Netherlands, Kajsa Ollongren, after the recent meeting of the Ukraine Defense Contact Group (UDCG).

The Netherlands has taken a proactive position in supporting Ukraine in the midst of the ongoing conflicts, highlighting its commitment to international security and cooperation. The ammunition, designed specifically for use in F-16 aircraft, should be purchased directly from the industry, ensuring timely support for Ukraine's military needs.

In addition to air support, the Dutch government is expanding its contributions to include unmanned aerial systems. With an investment of more than 200 million euros, the Netherlands plans to acquire and donate a substantial number of ISR (Intelligence Surveillance Reconnaissance) drones to Ukraine. These drones, which have already demonstrated their effectiveness on the battlefield, will be acquired in collaboration with other partners and the Ukrainian Armed Forces.

Further demonstrating its support, the Netherlands is fulfilling its previous commitment by sending F-16 fighters to Romania. These jets are not only intended for defensive operations, but also to serve as a crucial component of a training center for Ukrainian and Romanian pilots. This initiative, highlighted by the sending of aircraft along with spare parts and necessary ammunition, was detailed by General Onno Eichelsheim, Commander of the Dutch Armed Forces, during the UDCG meeting.

The Netherlands, in collaboration with Denmark and the United States, leads the UDCG air force coalition. A total of 18 Dutch F-16 jets have been designated for training purposes in Romania, while another 24 are being prepared for delivery in Ukraine. This preparation is a coordinated effort between the coalition partners, illustrating a united front in the provision of military assistance to Ukraine.

The Pentagon would have established "red lines" in relation to the use of Ukrainian F-16 fighters in the Russian-Ukrainian conflict, stating that they should only be used within the sovereign territory of Ukraine.

This stance was transmitted by Patrick Ryder, press secretary of the U.S. Department of Defense, in an interview with RFE/RL.

Tags: Military AviationF-16 Fighting FalconRNLAF - Royal Netherlands Air Force / Royal Dutch Air ForceWar Zones - Russia/Ukraine

Sharing

tweet

Fernando Valduga

Fernando Valduga

Aviation photographer and pilot since 1992, he has participated in several events and air operations, such as Cruzex, AirVenture, Dayton Airshow and FIDAE. He has works published in specialized aviation magazines in Brazil and abroad. He uses Canon equipment during his photographic work in the world of aviation.

Related news

MILITARY

USAF gives up installing a laser gun on AC-130J Ghostrider

21/03/2024 - 08:08

MILITARY

USAF announces that 2024 will be the last year of the A-10C Thunderbolt II Demonstration Team

20/03/2024 - 23:00

MILITARY

Danish Minister of Defense will visit Argentina this month to sign the sale of F-16 fighters

20/03/2024 - 17:49

MILITARY

India signs contracts to strengthen its fleet of Do-228 aircraft

20/03/2024 - 16:00

ARMAMENTS

Germany will buy 75 JASSM-ER cruise missiles from the US

20/03/2024 - 15:00

MILITARY

Algeria would have bought new Chinese drones WJ700

20/03/2024 - 14:00

[personalcareexpo]

Visa-free! 🎉Entry policy relaxed!🎉 Visa waiver added!🤝 Relax visa requirements for foreigners!😆

🐼Relaxing visa conditions for foreigners， More convenient for overseas visitors✈️ To visit exhibitions in China for business cooperation💼🥂 ! ! !

In 2023, the transit policy and visa process will be optimized, international flights will resume and increase at a faster pace, and multiple entry favorable policies will further facilitate international business exchanges. China's door to the world will open wider and wider!🐼💖🤗

01✨

Shanghai port issued a new visa-free transit reminder📣 The National Immigration Bureau issued a new visa-free transit policy in November, 23📣

At present, the 72/144-hour visa-free transit policy is implemented at 31 ports in 23 cities in 18 provinces for people from 54 countries. Namely Austria, Belgium, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Italy, Latvia, Lithuania, Luxembourg, Malta, Netherlands, Poland, Portugal, Slovakia, Slovenia, Spain, Sweden, Switzerland, Monaco, Russia, United Kingdom, Ireland, Cyprus, Bulgaria, Romania, Ukraine, Serbia, Croatia, Bosnia and Herzegovina, Montenegro, North Macedonia, Albania, Belarus, Norway, the United States, Canada, Brazil, Mexico, Argentina, Chile, Australia, New Zealand, South Korea, Japan, Singapore, Brunei, the United Arab Emirates, Qatar and other countries, totaling 54 countries with valid international travel documents and confirmed dates and seats within a limited time. Persons from 54 countries who transit from China to a third country (region), with valid international travel documents, and connecting passenger tickets with fixed dates and seats within a limited time, may apply for transit visa exemption to the port entry inspection authorities of the cities that implement the transit visa exemption policy, and the exit border inspection authorities will handle the temporary entry formalities for them. The duration of visa-free stay starts from 00:00 on the next day of entry.

❤️[Please see the table at the bottom for details of Shanghai ports]👇👇

02✨

📢New news on visa-free policy released in November 📢China’s new visa-free policy promotes high-level opening-up

On November 24, 2023, the Chinese Ministry of Foreign Affairs announced that China has decided to try to expand the scope of unilateral visa-free countries and implement a unilateral visa-free policy for ordinary passport holders from six countries: France, Germany, Italy, the Netherlands, Spain, and Malaysia. From December 1, 2023 to November 30, 2024, ordinary passport holders from the above countries who come to China for business, tourism, visiting relatives and friends, and transit for no more than 15 days can enter China without a visa.

03✨

New news on convenient foreign personnel coming to China released in January📣 The National Immigration Administration has officially implemented five measures to facilitate foreign nationals to come to China📣

Another good news has come recently. Starting from January 11, the National Immigration Administration has officially implemented five measures to facilitate foreigners coming to China, which mainly include:

Relax the conditions for foreigners coming to China to apply for port visas. For foreigners who urgently need to come to China to engage in non-diplomatic and official activities such as business cooperation, visits and exchanges, investment and entrepreneurship, visiting relatives, and handling private affairs, and who do not have time to apply for a visa abroad, they can apply for a port visa entry to the port visa authority with relevant proof materials such as invitation letters.

For foreigners, 24-hour direct transit passengers at nine international airports including Shanghai Pudong, Beijing Capital, Beijing Daxing, Hangzhou Xiaoshan, Xiamen Gaoqi, Guangzhou Baiyun, Shenzhen Bao'an, Chengdu Tianfu, and Xi'an Xianyang are exempted from border inspection procedures.

Foreigners in China can apply for visa extension, replacement and reissue at their nearest location.

Foreigners in China who need to enter and exit multiple times can apply for a re-entry visa.

Simplify the application materials for visa documents for foreigners in China.

04✨

📢Starting from February 9, China and Singapore will exempt each other from visas

On January 25, representatives from the government of the People's Republic of China and the government of the Republic of Singapore signed the 'Agreement between the Government of the People's Republic of China and the Government of the Republic of Singapore on Mutual Visa Exemption for Ordinary Passport Holders' in Beijing. The agreement will officially enter into force on February 9, 2024 (Lunar New Year’s Eve). By then, people from both sides holding ordinary passports can enter the other country without a visa to engage in tourism, family visits, business and other private affairs, and their stay shall not exceed 30 days. If you enter the other country to engage in activities that require prior approval, such as work or news reporting, or plan to stay in the other country for more than 30 days, you must obtain the corresponding visa before entering the other country.

As of January 25, China has concluded mutual visa exemption agreements covering different passport types with 157 countries, and has reached agreements or arrangements with 44 countries to simplify visa procedures. Comprehensive mutual visa exemption has been achieved with 22 countries including Singapore, Maldives and Kazakhstan. In addition, more than 60 countries and regions offer visa-free or visa-on-arrival convenience to Chinese citizens. The convenience for Chinese citizens to leave the country has been greatly improved, and the 'gold content' of Chinese passports will become increasingly valuable. (Source: CCTV News)

05✨

Starting from March 1, China and Thailand will exempt each other from visas📣

On January 28, the government of the People's Republic of China and the Royal Government of Thailand held a signing ceremony in Bangkok for an agreement on mutual visa exemption for ordinary passport holders. The agreement will take effect from March 1, 2024.

After the news was released, data from a travel platform showed that the search popularity of Thailand-related keywords on the platform increased by more than 7 times compared with the previous day. Among them, air tickets and hotels increased by more than 6 times compared with the previous day. (Source: CCTV News)

In addition, recently, China has stated that it will grant unilateral visa-free treatment to Sweden and Ireland. This is the second time that China has granted visa-free treatment to European countries after France, Germany, the Netherlands, Spain, and Italy.

#visa #China #chinesevisa #visafree #entrypolicy #visawaiver #businessinchina #transitpolicy #internationalflights #internationalbusinessexchanges #business #Shanghaiport #transitvisaexemption #tourism #visitrelatives #visitfriends

[savibangar]

Tooth Replacement Market Size, Share, and End User 2031

Meticulous Research®, a leading global market research firm, has released a report titled “Tooth Replacement Market by Product [Dental Implants (Titanium, Zirconium), Dental Prosthetics (Bridges, Crowns, Dentures, Veneers, Abutments), Bone Graft, Sutures, CAD/CAM, Scanner], End User [Dental Laboratory, Clinic, DSO] - Global Forecast to 2031.” 

Download Research Report Sample @ https://www.meticulousresearch.com/download-sample-report/cp_id=3155

According to this report, the tooth replacement market is projected to grow at a   CAGR of 7.7% from 2024, reaching approximately   $30.6 billion by 2031. Growth drivers include the high incidence of edentulism and dental caries, increasing disposable incomes, and the rising adoption of digital dentistry among practitioners. However, the market faces challenges from the high costs of dental implants and procedures, as well as complications related to dental treatments.

Dental service organizations (DSOs)   are enhancing access to affordable care for a broader patient base. With financial backing, DSOs provide essential business and management resources, allowing dental professionals to concentrate on delivering quality care without the burden of administrative tasks. This trend has led to the growth of DSOs, which have become integral to the dental industry, enabling clinics to serve larger patient populations with a wider array of services.

Key Players

Key Players The key players operating in the tooth replacement market are Straumann AG (Switzerland), Dentsply Sirona Inc. (U.S.), ZimVie Inc. (U.S.), Envista Holdings, Corporation (U.S.), OSSTEM IMPLANT CO. LTD (South Korea), Dentium CO. LTD. (South Korea), Kulzer GmbH (Germany), Ultradent Products, Inc. (U.S.), Ivoclar Vivadent AG (Liechtenstein), COLTENE Group (Switzerland), Bicon LLC (U.S.) Implant Direct Corporation (U.S.), 3SHAPE A/S (Denmark), Midmark Corporation (U.S.), PLANMECA OY (Finland), Align Technology Inc. (U.S.), Condor Technologies NV (Belgium), CAMLOG Biotechnologies GmbH (Switzerland), AVINENT IMPLANT SYSTEM, S.L.U. (Spain), and Neoss Ltd. (U.K.).

Tooth Replacement Market: Future Outlook

The tooth replacement market is categorized by   Product Type   into dental implants, dental prosthetics, dental surgical supplies, CAD/CAM systems, and dental scanners. The   dental scanners segment   is expected to experience the highest growth rate during the forecast period, driven by the prevalence of edentulism, advancements in scanner technology, and a growing preference for same-day dental implant procedures.

Browse in depth @  https://www.meticulousresearch.com/product/tooth-replacement-market-3155

The integration of   augmented reality (AR)   and   artificial intelligence (AI)   with intraoral 3D scanning technology offers significant potential for enhancing dental imaging. AR can provide an immersive experience for both dentists and patients, improving understanding of dental structures and treatment options. Additionally, AI can analyze 3D scans for quick evaluations and optimized treatment recommendations, enhancing the accuracy and personalization of dental care.

By   end user  , the market includes dental clinics and hospitals, dental laboratories, DSOs, and academic and research institutes. In 2024, the   dental clinics and hospitals segment   is anticipated to hold the largest market share, largely due to the adoption of digital dentistry, which includes advanced imaging and 3D printing technologies. These innovations facilitate precise diagnostics and treatment planning, improving patient outcomes.

Traditional dental implants often require multiple visits and long wait times. In contrast, 3D printing technology enables dentists to design and create custom implants quickly, allowing for same-day delivery of implants and prosthetics.

Geographic Review

This report analyzes key regions, offering a comprehensive view of the tooth replacement market across   North America (U.S. and Canada), Europe (Germany, France, U.K., Italy, Spain, Switzerland, Netherlands, RoE), Asia-Pacific (Japan, China, India, Australia, South Korea, and RoAPAC), Latin America (Brazil, Mexico, and RoLATAM), and the Middle East & Africa  . North America is projected to lead the market in 2024, followed by Europe and Asia-Pacific. Factors contributing to North America's significant market share include a rising incidence of dental disorders, high purchasing power, skilled dental professionals, a well-established dental care sector, and increasing use of CAD/CAM technologies.

Request Customization Report @  https://www.meticulousresearch.com/request-customization/cp_id=3155

Related Research Report:

Dental Materials Market by Type (Ceramics, Metal-Ceramics, Amalgam, Resin-based Composites, Glass Ionomer, Biomaterials {Bone Grafts, Membrane}, Bonding Agents), End User (Dental Lab, Dental Manufacturer, Clinics, Research) - Global Forecast to 2030 >> https://www.meticulousresearch.com/product/dental-materials-market-3182

Dental 3D Printing Market by Product (Service, Printer, Scanner, Material [Polymer, Metal, Zirconia, Alumina]) Technology (Polyjet, FDM, SLS, Vat Photopolymerization) Application (Orthodontics, Prosthodontics, Implant) End User—Global Forecast to 2031 >> https://www.meticulousresearch.com/product/dental-3d-printing-market-5487

[theborderlessworld]

Italy, France, Germany: 38 European countries can now visit China visa-free

China's rapidly expanding visa-free scheme aims to boost tourism.

China's visa-free list continues to grow, with eight more European countries being added.

Citizens of Bulgaria, Romania, Malta, Croatia, Montenegro, North Macedonia, Estonia and Latvia have now been granted visa waivers for the Asian nation.

Tourists from these countries, as well as Japan, will be able to enter China visa-free from 30 November 2024 until 31 December 2025.

Passport holders from Andorra, Finland, Iceland, Liechtenstein, Monaco, Slovakia and Norway were recently added to the list, which grants them stays in China of up to 30 days without a visa.

Cyprus, Denmark, Greece, Portugal and Slovenia were granted the access in October.

It brings the total number of European countries granted visa-free access up to 38.

In July, tourists from Poland, Australia and New Zealand were also granted unrestricted entry to China until the end of 2025.

Since the start of 2024, the scheme has been announced in stages, with various European nations and Malaysia also gaining visa-free access. It aims to encourage more people to visit China for business and tourism, and promote exchanges between Chinese citizens and foreign nationals.

Which European countries can travel to China visa-free?

Citizens of 38 European countries can stay in China without a visa for up to 30 days.

The full list of European countries now includes Andorra, Austria, Belgium, Bulgaria, Croatia, Cyprus, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Liechtenstein, Luxembourg, Malta, Monaco, Montenegro, the Netherlands, North Macedonia, Norway, Poland, Portugal, Romania, Slovakia, Slovenia, Spain and Switzerland. Tourists from these countries will be allowed to enter China for short stays without a visa until the end of next year.

The aim is “to facilitate the high-quality development of Chinese and foreign personnel exchanges and high-level opening up to the outside world,” Foreign Ministry spokesperson Mao Ning said at a briefing on the initial announcement made in November.

International travel to China is still bouncing back

China's strict pandemic measures, which included required quarantines for all arrivals, discouraged many people from visiting for nearly three years. The restrictions were lifted early last year, but international travel has yet to bounce back to pre-pandemic levels.

China previously allowed citizens of Brunei, Japan and Singapore to enter without a visa but suspended that after the COVID-19 outbreak. It resumed visa-free entry for Brunei and Singapore in July but has not done so for Japan.

In 2023, China recorded 35.5 million entries and exits by foreigners, according to immigration statistics. That compares to 97.7 million for all of 2019, the last year before the pandemic.

From July to September this year, China recorded 8.2 million entries by foreigners, of which 4.9 million were visa-free, the official Xinhua News Agency said, quoting a Foreign Ministry consular official.

The Chinese government has been seeking foreign investment to help boost a sluggish economy, and some businesspeople have been coming for trade fairs and meetings, including Tesla's Elon Musk and Apple's Tim Cook. Foreign tourists are still a rare sight compared to before the pandemic.

How else is China simplifying travel for Europeans?

Last year saw a surge in interest in China as a tourist destination among Europeans.

Data from online travel agency Trip.com showed a 663 per cent increase in overall bookings from Europe to China compared to 2022, and an almost 29 per cent increase on 2019.

The United Kingdom and Germany were among the top 10 sources of inbound travellers to China globally, the data shows.

Shanghai remains the most popular destination among Europeans with its alluring blend of modernity and tradition, followed by Beijing, Guangzhou and Shenzhen.

Sanya, a beachside city on the southern end of China’s Hainan Island, and Chengdu - the capital of southwestern China's Sichuan province - are emerging destinations.

Beyond it's new visa-free schemes, the country is further encouraging inbound tourism by promoting cultural and historical attractions in partnership with Trip.com. China is also enhancing tourism infrastructure by investing in technology, travel guides and e-payment systems.

Source: https://www.euronews.com/travel/2024/11/22/china-aims-to-boost-tourism-by-giving-visa-free-entry-to-these-five-european-countries

[theroyalsandi]

Danish Royal Family - Queen Mary arrives at Schloss Bellevue palace to celebrate the 25th anniversary of the Nordic Embassies in Berlin, Germany. (Photo by Sean Gallup) | October 21, 2024

[industrynewsupdates]

Exploring the Growth of ePharmacyMarket: What You Need to Know

The global ePharmacy market size is expected to reach USD 255.6 billion by 2030 and is expected to grow at a CAGR of 20.4% over the forecast period, according to a new report by Grand View Research, Inc.  

Factors driving the adoption of ePharmacy include the improved access to online & web-based services, increasing awareness regarding e-commerce among consumers, rise in the number of internet users, and a surge in the aging population experiencing difficulty to visit pharmacies. In addition, benefits, such as affordability, convenience, and ease in the availability of medicines, are boosting the adoption of these platforms. High treatment costs are driving the demand for low-cost healthcare services, which, in turn, is bolstering the adoption of online pharmacies owing to the lucrative offers, such as price discounts, provided by them.

The COVID-19 pandemic has positively impacted the market growth and transformed the fortunes of ePharma companies owing to increasing consumer switch from traditional buying towards online purchases of general medications and medical devices, such as oximeters, thermometers, and health supplements. As per an article published by Economic Times in July 2021, the number of households utilizing ePharmacy services grew 2.5 times to 9.0 million during the pandemic. Moreover, the second wave of the Covid-19 epidemic has prompted a spike in demand for medical gadgets, personal protective equipment (PPE), as well as health supplements, and frequently accessible medications in the market.

Gather more insights about the market drivers, restrains and growth of the ePharmacy Market

ePharmacy Market Report Highlights

• North America dominated the market in 2021 owing to the increased prevalence of chronic diseases, developed healthcare infrastructure, and penetration of IT in healthcare across the region. According to Clarivate Analytics, the usage of internet pharmacies has climbed by 17% in the U.S. during the previous year. Consumers aged 18 to 34 are the most likely to use it

• Industry players in this market have significantly expanded their customer base as well as their product & service offerings to keep up with the growing needs of the consumers. As a result, in 2021 March, One of the U.K.'s digital prescription businesses has been bought by the corporation that runs the Rowlands drugstore chain and the Numark pharmacy membership business

• The main focus of these players is on increasing the Customer Lifetime Value (CLTV) by catering to their healthcare needs in a comprehensive manner, as various online pharmacies have started offering additional services like e-diagnostics, e-consultation, and retailing of health & wellness products

• Furthermore, a rise in the number of strategic initiatives is aiding market growth. For instance, in August 2020, Amazon India announced the launch of Amazon Pharmacy in Bengaluru, India. In June 2021, PharmEasy is purchasing a controlling share in Thyrocare Technologies, a diagnostics company. This alliance will provide huge potential and synergies for the whole Indian healthcare ecosystem of customers, physicians, and suppliers

Browse through Grand View Research's Healthcare IT Industry Research Reports.

• The global FemTech market size was estimated at USD 39.29 billion in 2024 and is expected to grow at a CAGR of 16.37% from 2025 to 2030.

• The global teledentistry market size was estimated at USD 2.02 billion in 2024 and is projected to grow at a CAGR of 15.3% from 2025 to 2030.

ePharmacy Market Segmentation

Grand View Research has segmented the global ePharmacy market based on drug type, and region:

ePharmacy Drug type Outlook (Revenue, USD Million, 2017 - 2030)

• Prescription drug

• Over-the-counter drug (OTC)

ePharmacy Regional Outlook (Revenue, USD Million, 2017 - 2030)

• North America

o U.S.

o Canada

• Europe

o Germany

o U.K.

o Italy

o Spain

o France

o Russia

o Denmark

o Sweden

o Norway

• Asia Pacific

o Japan

o China

o India

o Australia

o Singapore

o South Korea

o Thailand

• Latin America

o Brazil

o Mexico

o Argentina

• MEA

o South Africa

o Saudi Arabia

o UAE

o Kuwait

Order a free sample PDF of the ePharmacy Market Intelligence Study, published by Grand View Research.

[global-research-report]

How Clinical Trial Supplies Are Changing the Landscape of Clinical Research

Clinical Trial Supplies Industry Overview

The global clinical trial supplies market size was estimated at USD 3.97 billion in 2030 and is anticipated to grow at a compound annual growth rate (CAGR) of 6.5% from 2024 to 2030. Increasing volume of clinical trial studies coupled with the growing complexity in conduction of these trials are some of the major factors driving the market growth.

Globally, an increase in the prevalence of chronic diseases and the rapidly aging population are expected to drive the growth of R&D of biologics, which is expected to further propel the demand for efficient clinical supplies and contribute to the growth of the clinical trial supplies industry. Furthermore, an increase in the demand for orphan drugs and high investment in the R&D of rare diseases are also expected to contribute toward the development of biologic drugs. Thus, owing to these factors, this segment is likely to witness significant growth during the forecast period.

Gather more insights about the market drivers, restrains and growth of the Clinical Trial Supplies Market

For instance, in 2022, Novartis invested around USD 10 billion in research and development. It also secured 23 approvals in the European Union, Japan, China, and the U.S. for new drugs and rare diseases. The company is also conducting 44 ongoing phase III programs in India with 17 clinical programs running in rare diseases such as atypical hemolytic uremic syndrome (aHUS), Immune thrombocytopenic purpura (ITP), spinal muscular atrophy (SMA), and Lupus Nephritis.

Direct-to-Patients (DTP) is an upcoming segment in the distribution of clinical trial supplies, which is expected to be the future model of distribution. DTP is one of the emerging models that involves delivering drugs to patients directly to create patient-centric trials. This would facilitate fewer visits to the site and reduce the burden on participants. The COVID-19 outbreak has led to the increased adoption of such a model, to continue clinical trial studies with minimum disruption. In addition, patient retention and a diverse pool of patients worldwide are some of the notable reasons that can be attributed to the high adoption of this model.

Browse through Grand View Research's Medical Devices Industry Research Reports.

The S. donor egg IVF services market size was estimated at USD 398.5 million in 2024 and is projected to grow at a CAGR of 4.4% from 2025 to 2030

The global electro-medical and electrotherapeutic apparatus market size was estimated at USD 66.2 billion in 2024 and is projected to grow at a CAGR of 6.4% from 2025 to 2030.

Clinical Trial Supplies Market Segmentation

Grand View Research has segmented the global clinical trial supplies market based on clinical phase, product/service, end-use, therapeutic use, and region:

Clinical Trial Supplies Clinical Phase Outlook (Revenue, USD Billion, 2018 - 2030)

Phase I

Phase II

Phase III

Others

Clinical Trial Supplies Product/Service Outlook (Revenue, USD Billion, 2018 - 2030)

Manufacturing

Storage & distribution

Cold chain based

Non-cold chain based

Supply chain management

Clinical Trial Supplies End-Use Outlook (Revenue, USD Billion, 2018 - 2030)

Pharmaceuticals

Biologics

Medical device

Others

Clinical Trial Supplies Therapeutic Use Outlook (Revenue, USD Billion, 2018 - 2030)

Oncology

CNS

Cardiovascular

Infectious disease

Metabolic disorders

Others

Clinical Trial Supplies Regional Outlook (Revenue, USD Billion, 2018 - 2030)

North America

US             

Canada

Europe

UK

Germany

France

Italy

Spain

Denmark

Sweden

Norway

Asia Pacific

Japan

China

India

Australia

South Korea

Thailand

Latin America

Brazil

Mexico

Argentina

Middle East & Africa

South Africa

Saudi Arabia

UAE

Kuwait

Key Companies profiled:

Almac Group

Biocair

Catalent Inc.

KLIFO

Movianto

PCI Pharma Services

Sharp Services, LLC

Thermo Fischer Scientific Inc.

Marken

PAREXEL International Corporation

Recent Developments

In February 2023,Catalent completed a USD 2.2 million expansion of its clinical supply facility in Singapore. This expansion has enlarged the site's footprint to 31,000 square feet, providing room for installing 35 new freezers dedicated to ultra-low temperature (ULT) storage.

In January 2023,ASLAN Pharmaceuticals and Thermo Fisher Scientific entered into a partnership to manufacture a high concentration formulation of Eblasakimab for upcoming studies. Thermo Fisher Scientific will contribute its expertise in biologic manufacturing and scale-up capacity to oversee a clinical supply of Eblasakimab for the anticipated Phase 3 studies.

In July 2023,Almac Sciences announced the opening of a custom-built GMP warehouse and dispatch hub at Almac Group’s global headquarters in Craigavon, UK. The facility will support all the manufacturing and lab activities of Active Pharmaceutical Ingredients from development to their commercialization.

Order a free sample PDF of the Clinical Trial Supplies Market Intelligence Study, published by Grand View Research.

[031cinephile]

COMPLICATED FREEDOMS at the 11th EUROPEAN FILM FESTIVAL in SOUTH AFRICA

Film-lovers can look forward to an entertaining and provocative array of new award-winning films from Europe as the European Film Festival returns for its 11th edition in South Africa from 10-20 October.  Women challenging patriarchy and convention; relationships and independence; humour, satire and surrealism; coming-of-age stories; dysfunctional families; grumpy old men; restless youth; the pursuit of dreams; a realistic rom-com; and a riotous hip-hop biopic - all this and more.

Presenting films from 14 countries, and including two Oscar nominations, the festival is a showcase of high-quality cinema from the film industries in the respective participating countries of Belgium, Denmark, France, Georgia, Germany, Ireland, Italy, The Netherlands, Poland, Portugal, Spain, Switzerland, Ukraine, and the United Kingdom.

“The films all speak to the topic of Freedom in one or the another, from the personal to the political, and often both,” says Magdalene Reddy, co-director of the festival.  “Whether it is a developmental journey, a process of unfolding, an illumination, or a result of political changes in the world around us, Freedom comes at times of its own choosing, and one doesn't always know what it looks like until you get there.  The films this year offer a multi-faceted and evocative glimpse of what freedom means to a wide-ranging cast of characters and in an equally diverse range of situations – Complicated Freedoms!”

Sandra Kramer, EU Ambassador to South Africa, comments:  “We are delighted to bring to you the 11th edition of the European Film Festival in South Africa with a carefully curated selection of films from several EU Member States as well as from Georgia, Switzerland, Ukraine, and the United Kingdom. This year, we celebrate the transformative power of cinema in exploring the topic of freedom through the lens of talented filmmakers from across the world. Let’s gather to appreciate these stories that remind us of the responsibility to protect and promote the freedoms that unite us all.”

Cinema screenings take place in Johannesburg at Sterkinekor’s The Zone in Rosebank, and in Cape Town at The Labia.  Eleven of the films will be available in the free programme of online streaming accessible across South Africa during the festival period of 10-20 October.  For more information visit www.eurofilmfest.co.za

The European Film Festival 2024 is a partnership project of the Delegation of the European Union to South Africa and 14 European embassies and cultural agencies in South Africa:  the Embassies of Belgium, Denmark, Georgia, Ireland, Italy, the Netherlands, Poland, Portugal, Spain, Switzerland, Ukraine, and the British Council, Camoes Institute of Portugal, French Institute in South Africa, Goethe-Institut, Italian Cultural Institut, and Wallonie-Bruxelles International, The festival is organised in cooperation with Cineuropa and coordinated by Creative WorkZone.

[ifreakingloveroyals]

Through the Years → Queen Mary of Denmark (940/∞) 22 October 2024 | Queen Mary of Denmark waves to people in front of the Schleswig-Holstein state government building in Kiel, Germany. The visit of Schleswig-Holstein and the Danish minority will mark the end of the 2-day visit of the Danish Royal Couple to Germany. (Photo by Gregor Fischer/Getty Images)

[cargoshiptrip]

Friday 27 September 2024

Antwerp, 11:00.

Overnight Pulpca sailed from Tilbury, UK to Antwerp, Belgium. This is the ship I’ll be joining this evening for its next leg to Finland. I’ve instructions to arrive at the port terminal 16.30-18.30. But first I’ve to visit the Immigration Office to be stamped out of Schengen. It’s a 20 min taxi to Blauwhoefstraat…

It will be interesting to see if they pickup the fact I’ve been in Schengen 150 days… I’ve permanent residency in Italy, but there’s nothing on my UK passport to say that. I’ve got my Italian ID card if things get awkward.

Still lots unclear…. Am I the only passenger? What’s the route - some ships use the Kiel Canal across Germany, others go around Denmark. How much freedom do I have on the ship? Can I get off in Finland? What’s the WiFi password?!

A few last minute purchases in Antwerp before I leave, hat & gloves. And seasickness tablets!

The ships

Transfennica transports goods between Finland and Europe with six Spliethoff type ro-ro vessels. The shipping company is currently part of the Dutch Spliethoff group.

These ships fly the Dutch flag and have a length of 205 m and a breadth of 25,5 m.  They have a container capacity of 640 TEU, 20ft equiv units, 2,900 lane metres of deck space and a speed in excess of 22 knots and are ice-strenghtened to ice class 1 A Super.

Fin stabilizers ensure a safe passage in rough weather. Ships are equipped with two medium speed main engines, together with an output of 25,200 kW. The two bow thrusters produce 850 kW each.

Spliethoff Con-Ro ships are M/s: Timca(2006), Kraftca (2006), Genca (2007), Trica (2007), Pulpca (2008), Plyca (2009).

I’m still puzzled what’s in this for Transfennica - or the other shipping lines? Surely having some random off the street on your ship brings some risk you could do without? The few €€ they make out of me must be insignificant compared to the economics of running these ships.

The last thing a railway or airline wants is a passenger getting involved with the operational side. Isn’t this like an airline selling off the jumpseat in the cockpit? Or a railway selling the second man’s seat in the loco?!

[adityarana1687-blog]

On-body Injectors Market Size To Reach $12.7 Billion By 2030

The global on-body injectors market size is expected to reach USD 12.7 billion by 2030, registering a CAGR of 14.9% from 2024 to 2030, according to a new report by Grand View Research, Inc. The on-body injectors increase patient adherence to medication by offering easy-to-use, less pain and enabling extended drug administration without frequent hospital visits. These advantages of on-body injectors are significantly increasing their popularity. Moreover, regions such as Asia Pacific, with developing healthcare infrastructure and rising adoption of advanced medical devices, offer huge opportunities for market growth over the forecast period.

The increasing concerns over needle stick injuries and the need to increase the safety for both patients and healthcare professionals by eliminating risks associated with needle insertion, drug preparation, and covering & disposing of needles, coupled with the increasing prevalence of chronic diseases such as cancer are some of the factors expected to drive the market growth over the forecast period.

According to the WHO agency International Agency for Research on Cancer (IARC), around 20 million people were diagnosed with cancer, and around 9.7 million mortalities occurred due to cancer in 2022. Several cancers and other chronic disease treatments require frequent injections of medications over extended periods. On-body injectors offer a convenient and potentially less disruptive alternative for patients to receive these medications compared to traditional hospital visits or self-administered injections, which can significantly increase their demand over the forecast period.

Request a free sample copy or view report summary: On-body Injectors Market Report

On-body Injectors Market Report Highlights

Based on the technology, the spring-based segment accounted for the largest revenue share of 40.89% in 2023 owing to their consistent pressure and speed, which ensures precise dosing

Based on technology, the rotary pump segment is expected to grow at the fastest CAGR of 15.1% during the forecast period owing to the high control offered by them in dispensing medications, minimizing the risk of dosing errors and maximizing therapeutic efficacy

Based on the application, the diabetes segment accounted for the largest revenue share in 2023 due to the high prevalence of type 2 diabetes, which requires frequent administration

Based on the application, the autoimmune diseases segment is expected to grow at the fastest CAGR owing to the rising prevalence of chronic autoimmune conditions such as multiple sclerosis, rheumatoid arthritis, and Inflammatory Bowel Diseases (IBD)

Based on the end use, the homecare segment accounted for the largest revenue share in 2023 owing to the growing preference for self-administration of medications for managing chronic conditions such as diabetes, autoimmune disorders, and cancer in homecare settings

In 2023, North America dominated with a share of 33.17%, driven by the presence of key market players, an increasing shift toward home care, and better access to advanced on-body injectors 

On-body Injectors Market Segmentation

Grand View Research has segmented the global on-body injectors market based on technology, application, end-use, and region:

On-body Injectors Technology Outlook (Revenue, USD Million, 2018 - 2030­)

Spring-based

Motor-driven

Rotary Pump

Expanding Battery

Other

On-body Injectors Application Outlook (Revenue, USD Million, 2018 - 2030)

Oncology

Diabetes

Cardiovascular Disease

Autoimmune Disease

Others

On-body Injectors End Use Outlook (Revenue, USD Million, 2018 - 2030)

Hospitals & Clinics

Home Care Settings

Others

On-body Injectors Region Outlook (Revenue, USD Million, 2018 - 2030)

North America

U.S.

Canada

Mexico

Europe

UK

Germany

France

Italy

Spain

Denmark

Sweden

Norway

Asia Pacific

Japan

China

India

Australia

South Korea

Thailand

Latin America

Brazil

Argentina

Middle East & Africa

South Africa

Saudi Arabia

UAE

Kuwait

List of Key Players in the On-body Injectors Market

West Pharmaceutical Services, Inc.

BD

Stevanato Group

Enable Injections

Nemera

Debiotech SA

AbbVie, Inc.

Coherus BioSciences, Inc.

Gerresheimer AG

E3D Elcam Drug Delivery Devices